The Clorox Company $CLX Shares Purchased by Parvin Asset Management LLC

Parvin Asset Management LLC lifted its stake in The Clorox Company (NYSE:CLX) by 338.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 16,030 shares of the company’s stock after purchasing an additional 12,370 shares during the quarter. Clorox comprises about 1.3% of Parvin Asset Management LLC’s holdings, making the stock its 18th largest holding. Parvin Asset Management LLC’s holdings in Clorox were worth $1,616,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Vermillion & White Wealth Management Group LLC acquired a new stake in shares of Clorox in the third quarter valued at approximately $25,000. Darwin Wealth Management LLC purchased a new position in Clorox in the second quarter valued at $29,000. Vision Financial Markets LLC boosted its holdings in Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares during the period. Ameriflex Group Inc. boosted its holdings in Clorox by 1,436.8% in the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares during the period. Finally, Elevated Capital Advisors LLC purchased a new position in Clorox in the fourth quarter valued at $43,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

NYSE CLX opened at $97.52 on Wednesday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The business’s 50-day moving average price is $96.26 and its 200 day moving average price is $105.05. The firm has a market cap of $11.79 billion, a P/E ratio of 15.83, a P/E/G ratio of 0.50 and a beta of 0.56.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the company posted $1.45 earnings per share. The business’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts expect that The Clorox Company will post 5.61 earnings per share for the current year.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.63% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of recent research reports. Royal Bank Of Canada decreased their target price on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a report on Thursday, April 9th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $91.00 target price on shares of Clorox in a report on Friday, May 1st. Barclays decreased their target price on Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, May 1st. BNP Paribas Exane decreased their target price on Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a report on Tuesday, May 12th. Finally, Morgan Stanley decreased their target price on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, Clorox currently has an average rating of “Reduce” and a consensus price target of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.